Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic compounds comprised of anti-Fc receptor antibodies

Therapeutic compounds comprised of anti-Fc receptor antibodies

US Patent 6410690 · Granted Jun 25, 2002

Estimated economic value: $8,630,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Agonistic antibodies that bind human CD40 and uses thereof2025
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs2022
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs2022
Antibodies against MICA and/or MICB and uses thereof2022
Methods of inducing or enhancing an immune response comprising administering ago2021
Nucleic acids encoding agonistic antibodies that bind CD402020
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer2020
Agonistic antibodies that bind CD402020
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer2017
Antibodies against clostridium difficile toxins and uses thereof2015
Monoclonal antibodies to dendritic cells2015
Human CTLA-4 antibodies and their uses2014